Other disease areas

We have medicines and vaccines in other disease areas that have an important impact for patients. As such, we are selectively active in the areas of autoimmunity, infection & vaccines, neuroscience and gastroenterology, where we follow an opportunity-driven approach and often work through partnerships.

Explore our latest work

Inflammation and Autoimmunity

Seeking to develop best-in-class and first-in-class treatments for a breadth of inflammatory and autoimmune diseases with unmet medical needs.

Infection and Vaccines

We work to protect patients against the burden of influenza, respiratory syncytial virus (RSV) and bacterial infections, particularly those resistant to current antibiotics.

Neuroscience

With a rich heritage and a research and development focus on specific aspects of neurodegenerative diseases, analgesia and psychiatry, AstraZeneca continues to push the boundaries of science in neuroscience in collaboration with other innovative partners across industry and academia.

Eosinophil-Driven Diseases (EDDs)

Expanding the reach of our medicines to address these inflammatory illnesses in which elevated eosinophils are a direct cause or are thought to play a critical role.